Over the last two decades, global health has seen a significant shift as private philanthropy increasingly fills the void left by unpredictable public funding. Major foundations like the Gates Foundation, Bloomberg Philanthropies, and the Chan Zuckerberg Initiative have become key players, contributing substantially to the budgets of organizations such as the World Health Organization (WHO). These philanthropic entities are not only funding health initiatives but also producing vital data and metrics that shape how global health issues are understood and prioritized. For instance, the Institute of Health Metrics and Evaluation (IHME), funded by the Gates Foundation, has developed the Global Burden of Disease (GBD) metrics, which have become central to global health decision-making. This dominance of philanthropic data has led to a calculative approach to health interventions, favoring those that are easily measurable and scalable, often sidelining more complex, structural solutions. While the intent to improve public health is commendable, the political implications of prioritizing certain health issues over others raise critical questions about the influence of private funding in global health governance.